{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P00533",
      "entity_text" : "EGFR",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "Organ" : [ "uberon:UBERON:0000479" ]
    }
  },
  "verbose_text" : "Lee et al [XREF_BIBR] obtained 60 tissue specimens in 133 patients treated with chemotherapy and erlotinib for DNA analysis; EGFR overexpression was recorded in 12 of 28 (3%) patients, and only 6 of 60 (10%) patients had a KRAS mutation (codon 12), because the predictive value of tumor mutation status for response to erlotinib is limited by the small number of tissues; further investigation is needed to identify those patients who are likely to respond to erlotinib.",
  "reading_complete" : "2020-07-28T17:56:54Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T17:49:07Z",
  "trigger" : "overexpression",
  "evidence" : [ "EGFR overexpression" ],
  "pmc_id" : "5370815",
  "score" : 0
}